Skip to main content

Table 3 Anatomic Site and Summary Stage at Diagnosis for Cancer Cohort Members by Sex

From: The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship

 

Total

(N = 65,225)

Females

(N = 36,492)

Males

(N = 28,733)

Anatomic Site

N

N

%

N

%

Breast

15,080

14,962

99%

118

1%

Prostate

10,509

  

10,509

100%

Melanoma

9048

4280

47%

4768

53%

Colorectal

4717

2386

51%

2331

49%

Head and Neck

3055

1615

53%

1440

47%

Leukemia

3042

1343

44%

1699

56%

Lung

2917

1661

57%

1256

43%

Bladder

2416

538

22%

1878

78%

Cervical

2212

2212

100%

  

Endometrial

1994

1994

100%

  

Lymphoma

1751

869

50%

882

50%

Kidney and Ureter

1562

569

36%

993

64%

Brain and Other Nervous System

1550

1006

65%

544

35%

Pancreatic and Biliary

1371

651

47%

720

53%

Upper Gastrointestinal Tract

991

345

35%

646

65%

Othera

3010

2061

68%

949

32%

 

Total

(N = 65,225)

Females

(N = 36,492)

Males

(N = 28,733)

Summary Stageb

N

N

%

N

%

In-Situ

10,261

6897

19%

3364

12%

Local

32,354

16,864

46%

15,490

54%

Regional

10,243

6256

17%

3987

14%

Distant

7951

3893

11%

4058

14%

Benign/Borderline

1263

855

2%

408

1%

Unknown

1983

981

3%

1002

4%

Missing

1170

746

2%

424

1%

  1. aOther includes cancers of the following systems and sites: eye, musculoskeletal, genitourinary otherwise not listed, gynecologic otherwise not listed, condition-specific sarcomas, and unspecified/unknown cancers. bSEER general summary stage [8]